Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

被引:180
作者
Aurilio, Gaetano [1 ]
Cimadamore, Alessia [2 ]
Mazzucchelli, Roberta [2 ]
Lopez-Beltran, Antonio [3 ]
Verri, Elena [1 ]
Scarpelli, Marina [2 ]
Massari, Francesco [4 ]
Cheng, Liang [5 ]
Santoni, Matteo [6 ]
Montironi, Rodolfo [2 ]
机构
[1] European Inst Oncol IRCCS, Med Oncol Div Urogenital & Head & Neck Tumours, IEO, I-20141 Milan, Italy
[2] Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, I-60126 Ancona, Italy
[3] Cordoba Univ, Dept Surg, Med Sch, Cordoba 14071, Spain
[4] St Orsola Marcello Malpighi Hosp, Div Oncol, I-40138 Bologna, Italy
[5] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[6] Macerata Hosp, Oncol Unit, I-62100 Macerata, Italy
关键词
prostate cancer; androgen receptor; AR-V7; AR variants; AR antagonists; AR resistance; SPLICE VARIANTS; BINDING DOMAIN; MALIGNANT-TRANSFORMATION; PLASMA DNA; MUTATIONS; HORMONE; ENZALUTAMIDE; RESISTANCE; AR-V7; ABIRATERONE;
D O I
10.3390/cells9122653
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum androgens and the inhibition of androgen receptor (AR) is generally the first therapy adopted. However, the patient's response to androgen ablation therapy is variable, and 20-30% of PCa cases become castration resistant (CRPCa). Several mechanisms can guide treatment resistance to anti-AR molecules. In this regard, AR-dependent and -independent resistance mechanisms can be distinguished within the AR pathway. In this article, we investigate the multitude of AR signaling aspects, encompassing the biological structure of AR, current AR-targeted therapies, mechanisms driving resistance to AR, and AR crosstalk with other pathways, in an attempt to provide a comprehensive review for the PCa research community. We also summarize the new anti-AR drugs approved in non-metastatic castration-resistant PCa, in the castration-sensitive setting, and combination therapies with other drugs.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 89 条
[1]   The Molecular Taxonomy of Primary Prostate Cancer [J].
Abeshouse, Adam ;
Ahn, Jaeil ;
Akbani, Rehan ;
Ally, Adrian ;
Amin, Samirkumar ;
Andry, Christopher D. ;
Annala, Matti ;
Aprikian, Armen ;
Armenia, Joshua ;
Arora, Arshi ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barbieri, Christopher E. ;
Bauer, Thomas ;
Benz, Christopher C. ;
Bergeron, Alain ;
Beroukhim, Rameen ;
Berrios, Mario ;
Bivol, Adrian ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
dos Reis, Rodolfo Borges ;
Boutros, Paul C. ;
Bowen, Jay ;
Bowlby, Reanne ;
Boyd, Jeffrey ;
Bradley, Robert K. ;
Breggia, Anne ;
Brimo, Fadi ;
Bristow, Christopher A. ;
Brooks, Denise ;
Broom, Bradley M. ;
Bryce, Alan H. ;
Bubley, Glenn ;
Burks, Eric ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Canes, David ;
Carlotti, Carlos G. ;
Carlsen, Rebecca ;
Carmel, Michel ;
Carroll, Peter R. ;
Carter, Scott L. ;
Cartun, Richard ;
Carver, Brett S. ;
Chan, June M. ;
Chang, Matthew T. ;
Chen, Yu .
CELL, 2015, 163 (04) :1011-1025
[2]   Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study [J].
Aggarwal, Rahul ;
Huang, Jiaoti ;
Alumkal, Joshi J. ;
Zhang, Li ;
Feng, Felix Y. ;
Thomas, George V. ;
Weinstein, Alana S. ;
Friedl, Verena ;
Zhang, Can ;
Witte, Owen N. ;
Lloyd, Paul ;
Gleave, Martin ;
Evans, Christopher P. ;
Youngren, Jack ;
Beer, Tomasz M. ;
Rettig, Matthew ;
Wong, Christopher K. ;
True, Lawrence ;
Foye, Adam ;
Playdle, Denise ;
Ryan, Charles J. ;
Lara, Primo ;
Chi, Kim N. ;
Uzunangelov, Vlado ;
Sokolov, Artem ;
Newton, Yulia ;
Beltran, Himisha ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Stuart, Joshua M. ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) :2492-+
[3]   HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer [J].
Alyamani, Mohammad ;
Emamekhoo, Hamid ;
Park, Sunho ;
Taylor, Jennifer ;
Almassi, Nima ;
Upadhyay, Sunil ;
Tyler, Allison ;
Berk, Michael P. ;
Hu, Bo ;
Hwang, Tae Hyun ;
Figg, William Douglas ;
Peer, Cody J. ;
Chien, Caly ;
Koshkin, Vadim S. ;
Mendiratta, Prateek ;
Grivas, Petros ;
Rini, Brian ;
Garcia, Jorge ;
Auchus, Richard J. ;
Sharifi, Nima .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (08) :3333-3340
[4]   Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor [J].
Andersen, Raymond J. ;
Mawji, Nasrin R. ;
Wang, Jun ;
Wang, Gang ;
Haile, Simon ;
Myung, Jae-Kyung ;
Watt, Kate ;
Tam, Teresa ;
Yang, Yu Chi ;
Banuelos, Carmen A. ;
Williams, David E. ;
McEwan, Iain J. ;
Wang, Yuzhou ;
Sadar, Marianne D. .
CANCER CELL, 2010, 17 (06) :535-546
[5]   Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer [J].
Annala, Matti ;
Vandekerkhove, Gillian ;
Khalaf, Daniel ;
Taavitsainen, Sinja ;
Beja, Kevin ;
Warner, Evan W. ;
Sunderland, Katherine ;
Kollmannsberger, Christian ;
Eigl, Bernhard J. ;
Finch, Daygen ;
Oja, Conrad D. ;
Vergidis, Joanna ;
Zulfiqar, Muhammad ;
Azad, Arun A. ;
Nykter, Matti ;
Gleave, Martin E. ;
Wyatt, Alexander W. ;
Chi, Kim N. .
CANCER DISCOVERY, 2018, 8 (04) :444-457
[6]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[7]   ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J].
Armstrong, Andrew J. ;
Szmulewitz, Russell Z. ;
Petrylak, Daniel P. ;
Holzbeierlein, Jeffrey ;
Villers, Arnauld ;
Azad, Arun ;
Alcaraz, Antonio ;
Alekseev, Boris ;
Iguchi, Taro ;
Shore, Neal D. ;
Rosbrook, Brad ;
Sugg, Jennifer ;
Baron, Benoit ;
Chen, Lucy ;
Stenzl, Arnulf .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) :2974-+
[8]   Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer [J].
Azad, Arun A. ;
Volik, Stanislav V. ;
Wyatt, Alexander W. ;
Haegert, Anne ;
Le Bihan, Stephane ;
Bell, Robert H. ;
Anderson, Shawn A. ;
McConeghy, Brian ;
Shukin, Robert ;
Bazov, Jenny ;
Youngren, Jack ;
Paris, Pamela ;
Thomas, George ;
Small, Eric J. ;
Wang, Yuzhuo ;
Gleave, Martin E. ;
Collins, Colin C. ;
Chi, Kim N. .
CLINICAL CANCER RESEARCH, 2015, 21 (10) :2315-2324
[9]   Overcoming mutation-based resistance to antiandrogens with rational drug design [J].
Balbas, Minna D. ;
Evans, Michael J. ;
Hosfield, David J. ;
Wongvipat, John ;
Arora, Vivek K. ;
Watson, Philip A. ;
Chen, Yu ;
Greene, Geoffrey L. ;
Shen, Yang ;
Sawyers, Charles L. .
ELIFE, 2013, 2
[10]   Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer [J].
Barbieri, Christopher E. ;
Baca, Sylvan C. ;
Lawrence, Michael S. ;
Demichelis, Francesca ;
Blattner, Mirjam ;
Theurillat, Jean-Philippe ;
White, Thomas A. ;
Stojanov, Petar ;
Van Allen, Eliezer ;
Stransky, Nicolas ;
Nickerson, Elizabeth ;
Chae, Sung-Suk ;
Boysen, Gunther ;
Auclair, Daniel ;
Onofrio, Robert C. ;
Park, Kyung ;
Kitabayashi, Naoki ;
MacDonald, Theresa Y. ;
Sheikh, Karen ;
Vuong, Terry ;
Guiducci, Candace ;
Cibulskis, Kristian ;
Sivachenko, Andrey ;
Carter, Scott L. ;
Saksena, Gordon ;
Voet, Douglas ;
Hussain, Wasay M. ;
Ramos, Alex H. ;
Winckler, Wendy ;
Redman, Michelle C. ;
Ardlie, Kristin ;
Tewari, Ashutosh K. ;
Mosquera, Juan Miguel ;
Rupp, Niels ;
Wild, Peter J. ;
Moch, Holger ;
Morrissey, Colm ;
Nelson, Peter S. ;
Kantoff, Philip W. ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad ;
Rubin, Mark A. ;
Garraway, Levi A. .
NATURE GENETICS, 2012, 44 (06) :685-U107